EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Reliability and benefit of estimated continuous cardiac output measurement using shunt‐side SpO 2 monitor in hemodialysis

Koji Nakai iD, Yuichi Hirate, Takashi Nakajima, Atsushi Doi, Takeyuki Hiramatsu, Toshie Higaki, Aiko Nakai

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1111/1744-9987.14193 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Koji Nakai und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life and Health Sciences, Department of Clinical Engineering, Chubu University, Kasugai, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Cardiac Output, Arteriovenous Shunt, Surgical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Estimated continuous cardiac output (esCCO) is a novel technology that enables non‐invasive and continuous monitoring of cardiac output. We compared the concordance in accuracies among esCCO measurements in the shunt limb and non‐shunt limb.

Methods

In this single‐center prospective observational study, we include Japanese patients who underwent dialysis at our center between April 27, 2021, and February 28, 2023. Clinical accuracy of esCCO was evaluated in the shunted and non‐shunted bilateral digits. Agreement between the measurements was analyzed using Lin's congruent correlation and Bland–Altman analysis.

Results

For 43 individuals, Lin's concordance correlation coefficient was 0.9887 (95% confidence interval of 0.9886–0.9887) indicating good agreement. The values of esCCO measured in the shunt and non‐shunt limbs were compatible. The percentage errors for the 43 patients with arterio‐venous fistula (AVF) or arterio‐venous graft (AVG), 32 with AVF, and 11 with AVG were 9.3%, 9.3%, and 8.9%, respectively. Conclusion esCCO could be used in shunt as well as non‐shunt limbs during dialysis, allowing continuous and non‐invasive hemodynamic monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCardiac OutputArteriovenous Shunt, SurgicalHumansMaleFemaleProspective StudiesAgedMiddle AgedReproducibility of ResultsMonitoring, PhysiologicJapan

Stichwörter der Autor:innen

artificial endovascular shuntautologous endovascular shuntestimated continuous cardiac outputnon‐invasive blood pressure hemodialysis

Autor:innen und Institutionen

  • College of Life and Health Sciences, Department of Clinical Engineering, Chubu University, Kasugai, Japan.
  • Department of Nephrology, Nagoya Ekisaikai Hospital, Nagoya, Japan.
  • Department of Clinical Engineering, Nagoya Ekisaikai Hospital, Nagoya, Japan.
  • Department of Anesthesiology, Aichi Cancer Center, Nagoya, Japan.

ORCID-Profile: Koji Nakai

Zitieren

APA

Nakai, K., Hirate, Y., Nakajima, T., Doi, A., Hiramatsu, T., Higaki, T., & Nakai, A. (2025). Reliability and benefit of estimated continuous cardiac output measurement using shunt‐side SpO 2 monitor in hemodialysis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14193

Vancouver

Nakai K, Hirate Y, Nakajima T, Doi A, Hiramatsu T, Higaki T, et al. Reliability and benefit of estimated continuous cardiac output measurement using shunt‐side SpO 2 monitor in hemodialysis. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.14193

BibTeX
@article{Nakai2025,
  author = {Nakai, Koji and Hirate, Yuichi and Nakajima, Takashi and Doi, Atsushi and Hiramatsu, Takeyuki and Higaki, Toshie and Nakai, Aiko},
  title = {Reliability and benefit of estimated continuous cardiac output measurement using shunt‐side SpO 2 monitor in hemodialysis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1111/1744-9987.14193}
}
Kostenlos starten →